Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-017551

Chief Product Officer acquired 4,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Besch Doug Chief Product Officer 2024-02-15 Grant or award +4,000 7,848 D
Loading xslF345X05/wk-form4_1713968321.xml…